Gluten in pharmaceutical products: a scoping review.

ABSTRACT:

Background

Celiac disease (CD) is one of the most common gluten-related disorders. Although the only effective treatment is a strict gluten-free diet, doubts remain as to whether healthcare professionals take this restriction into consideration when prescribing and dispensing medicines to susceptible patients. This scoping review aimed to find out the current evidence for initiatives that either describe the gluten content of medicines or intend to raise awareness about the risk of prescribing and dispensing gluten-containing medicines in patients with CD and other gluten-related disorders.

Methods

A scoping review was conducted using three search strategies in PubMed/MEDLINE, TripDatabase and Web of Science in April 2021, following the PRISMA extension for scoping reviews (

SUBMITTER: Lizano-Diez I 

PROVIDER: S-EPMC8349483 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature